Literature DB >> 15210811

The low molecular weight GTPase RhoA and atypical protein kinase Czeta are required for TLR2-mediated gene transcription.

Nicole Teusch1, Eleuterio Lombardo, Jane Eddleston, Ulla G Knaus.   

Abstract

The Rho GTPases are molecular switches that regulate many essential cellular processes, including actin dynamics, gene transcription, cell cycle progression, cell adhesion, and motility. In this study, we report that stimulation of TLR2 in human epithelial and monocytic cells leads to rapid and transient activation of RhoA. RhoA cooperated with the canonical I-kappaB kinase-mediated pathway that induces the release of NF-kappaB, in regulating the trans activation of the NF-kappaB subunit p65/RelA by affecting Ser(311) phosphorylation, and subsequent cytokine production. Another consequence of TLR2 stimulation by bacterial derived products was the activation of atypical protein kinase C (PKC) zeta and association of this protein kinase with RhoA. Inhibition of PKCzeta decreased NF-kappaB activation and p65/RelA trans activation without affecting I-kappaBalpha degradation. The observation of a transient, stimulus-dependent association of RhoA with PKCzeta suggests that RhoA mediates at least partially its effect on gene transcription through atypical PKC. In contrast to previous studies, identifying Rac1-PI3K as an upstream element in TLR2-initiated response to NF-kappaB, PI3K signaling was not required for RhoA or PKCzeta activity. These results indicate that multiple GTPase-regulated pathways emerge from stimulated Toll receptors, controlling different aspects of NF-kappaB-mediated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210811     DOI: 10.4049/jimmunol.173.1.507

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients.

Authors:  Haobo Lin; Youjun Xiao; Guoqiang Chen; Di Fu; Yujin Ye; Liuqin Liang; Jinjin Fan; Xiuyan Yang; Lin Sun; Hanshi Xu
Journal:  Rheumatol Int       Date:  2010-05-15       Impact factor: 2.631

3.  Dual role for RhoA in suppression and induction of cytokines in the human neutrophil.

Authors:  Michael B Fessler; Patrick G Arndt; Ingo Just; Jerry A Nick; Kenneth C Malcolm; G Scott Worthen
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

4.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction.

Authors:  Junjie Xing; Nurgul Moldobaeva; Anna A Birukova
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

5.  aPKCζ affects directed cell migration through the regulation of myosin light chain phosphorylation.

Authors:  Daria Petrov; Inbal Dahan; Einav Cohen-Kfir; Shoshana Ravid
Journal:  Cell Adh Migr       Date:  2016-08-19       Impact factor: 3.405

6.  Toll-like receptor 2 mediates inhibition of HCO(3)(-) absorption by bacterial lipoprotein in medullary thick ascending limb.

Authors:  David W Good; Thampi George; Bruns A Watts
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-16

7.  PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.

Authors:  Sheng Yao; Alix Bee; Daniel Brewer; Andrew Dodson; Carol Beesley; Youqiang Ke; Laurence Ambroisine; Gabrielle Fisher; Heinrich Møller; Tim Dickinson; Patricia Gerard; Lu-Yu Lian; Janet Risk; Brian Lane; Paul Smith; Victor Reuter; Daniel Berney; Christine Gosden; Peter Scardino; Jack Cuzick; Mustafa B A Djamgoz; Colin Cooper; Christopher S Foster
Journal:  Genes Cancer       Date:  2010-05

8.  Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences.

Authors:  R William Vandivier; Tiffany R Richens; Sarah A Horstmann; Aimee M deCathelineau; Moumita Ghosh; Susan D Reynolds; Yi-Qun Xiao; David W Riches; Jonathan Plumb; Eric Vachon; Gregory P Downey; Peter M Henson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-24       Impact factor: 5.464

9.  ROCK I-mediated activation of NF-kappaB by RhoB.

Authors:  Pedro L Rodriguez; Sutapa Sahay; Oyenike O Olabisi; Ian P Whitehead
Journal:  Cell Signal       Date:  2007-08-08       Impact factor: 4.315

10.  RhoA GTPase activation by TLR2 and TLR3 ligands: connecting via Src to NF-kappa B.

Authors:  Maria Manukyan; Perihan Nalbant; Sylvia Luxen; Klaus M Hahn; Ulla G Knaus
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.